Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News FSD Pharma Inc C.HUGE

Alternate Symbol(s):  HUGE

Healthcare Cannabis
FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is... see more

Recent & Breaking News (CSE:HUGE)

Seasoned Healthcare Executive and Academic Luminary Larry Kaiser, MD, Joins FSD Pharma Board of Directors

Business Wire January 22, 2020

FSD Pharma to Ring Nasdaq Opening Bell on Wednesday, January 22, 2020

Business Wire January 17, 2020

Welcome to the Big Leagues: FSD Up-Lists to the NASDAQ

Jonathon Brown January 14, 2020

Zacks Research: FSD Debuts on the NASDAQ

Featured Submission January 13, 2020

InvestmentPitch Media Video Discusses FSD Pharma's New Listing on the Nasdaq Capital Market and Upcoming Biotech and Healthcare Conferences - Video Available on Investmentpitch.com

Newsfile January 10, 2020

The StockTalk Cannabis Report: Jan. 10, 2020

Dave Jackson January 10, 2020

FSD Pharma to Commence Trading on Nasdaq Capital Market Under Symbol 'HUGE'

Canada NewsWire January 9, 2020

FSD Pharma to Commence Trading on Nasdaq Capital Market Under Symbol 'HUGE'

Business Wire January 9, 2020

FSD Pharma gears up for new NASDAQ listing

Stockhouse Editorial January 6, 2020

FSD Pharma to Begin Trading on the NASDAQ Capital Market Under Symbol 'HUGE' on January 9, 2020

Business Wire January 6, 2020

FSD Pharma to Begin Trading on the NASDAQ Capital Market Under Symbol 'HUGE' on January 9, 2020

Canada NewsWire January 6, 2020

FSD Pharma Strengthens Management Team

Business Wire January 2, 2020

FSD Pharma Strengthens Management Team

Canada NewsWire January 2, 2020

InvestmentPitch Media Video Discusses FSD Pharma's Approval of Listing Application for Nasdaq Capital Market with trading Anticipated to Begin Shortly - Video Available on Investmentpitch.com

Newsfile December 17, 2019

FSD to make HUGE Move onto Nasdaq

Stockhouse Editorial December 16, 2019

IIROC Trade Resumption - HUGE

Canada NewsWire December 16, 2019

FSD Pharma Receives Approval to List its Shares on Nasdaq

Canada NewsWire December 16, 2019

FSD Pharma Receives Approval to List Its Shares on Nasdaq

Business Wire December 16, 2019

IIROC Trading Halt - HUGE

Canada NewsWire December 13, 2019

FSD Pharma to Present at Investor Summit on December 17

Business Wire December 13, 2019